Ignite Creation Date:
2025-12-25 @ 3:27 AM
Ignite Modification Date:
2026-05-20 @ 11:00 PM
Study NCT ID:
NCT00372905
Status:
TERMINATED
Last Update Posted:
2019-09-04
First Post:
2006-09-06
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase I/II Trial of VELCADE Plus Zevalin in Patients With Relapsed or Refractory Follicular Lymphoma
Sponsor:
Northwestern University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
NU 05H9
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |